Alpha Teknova (TKNO) Return on Capital Employed (2021 - 2026)
Alpha Teknova's (TKNO) quarterly Return on Capital Employed came in at 17.31% in Q1 2026, up 384.0% year-on-year from 3.58% in Q1 2025, and little changed on a QoQ basis from 17.31% in Q4 2025.
Alpha Teknova (TKNO) Return on Capital Employed (2021 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 6 years of Return on Capital Employed data on file, last reported at 17.31% in Q1 2026.
- On a quarterly basis, Return on Capital Employed rose 384.0% year-over-year to 17.31% in Q1 2026; TTM through Mar 2026 was 17.31%, a 384.0% increase from a year earlier, with the FY2025 full-year figure at 16.38%, up 687.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 17.31%, roughly flat from 17.31% in the prior quarter.
- Over the last five years, Return on Capital Employed for TKNO reached as high as 10.47% in Q1 2022 and fell as low as 49.14% in Q2 2023.
- Historically, Return on Capital Employed has averaged 25.51% across 5 years, with a median of 25.29% in 2022.
- Across the five-year window, Return on Capital Employed sank 3680 bps in 2023 and soared 1958 bps in 2024, its largest moves.
- Year by year, Return on Capital Employed stood at 34.16% in 2022, then grew by 16 bps to 28.54% in 2023, then increased by 17 bps to 23.72% in 2024, then advanced by 27 bps to 17.31% in 2025, then gained by 0 bps to 17.31% in 2026.
- Per Business Quant data, the three most recent Return on Capital Employed figures were 17.31% in Q1 2026, 17.31% in Q4 2025, and 17.62% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 8.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 27.36% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -1.50% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 21.43% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.46% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 20.04% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.24% |
| 10 | Alpha Teknova | 278.75 Mn | 260.97 Mn | 3.78 Mn | -17.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.31% |
| Dec 31, 2025 | -17.31% |
| Sep 30, 2025 | -17.62% |
| Jun 30, 2025 | -20.24% |
| Mar 31, 2025 | -21.15% |
| Dec 31, 2024 | -23.72% |
| Sep 30, 2024 | -28.52% |
| Jun 30, 2024 | -29.55% |
| Mar 31, 2024 | -29.41% |
| Dec 31, 2023 | -28.54% |
| Sep 30, 2023 | -30.63% |
| Jun 30, 2023 | -49.14% |
| Mar 31, 2023 | -38.24% |
| Dec 31, 2022 | -34.16% |
| Sep 30, 2022 | -25.29% |
| Jun 30, 2022 | -12.33% |
| Mar 31, 2022 | -10.47% |
| Dec 31, 2021 | -7.50% |
| Sep 30, 2021 | -3.92% |